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Recent studies (1-4) have shown that anti-Tac monoclonal antibody recognizes 
the  human  receptor  for  interleukin  2  (IL-2),  which  is  expressed  on  plasma 
membrane of T  cells activated by antigens or lectins.  Our  initial experiments 
showed  that  the  expression  of Tac  antigen  was  restricted  predominantly  to 
activated T  cells (1).  In a  murine  system, however,  it was reported  that  IL-2 
receptors were present at low levels on Thy-1-negative spleen cells activated with 
anti-Ig-plus factors when examined by radiolabeled human IL-2 (5).  Moreover, 
very recently Korsmeyer et al. (6) demonstrated the expression of Tac antigen 
in eight cases of hairy cell leukemia that proved to be B cell lineage malignancies, 
suggesting the possibility that IL-2 receptor may be expressed at certain stages 
of normal B cell development. 
In this study, we directly demonstrate the expression of Tac antigen on normal 
human B cells activated with Staphylococcus aureus Cowan I (SAC) by the method 
of two-color fluorescence analysis. In addition, we show here that SAC-activated 
B  cells  proliferate  in  response  to  immunoaffinity-purified IL-2  and  that  the 
proliferative response is completely inhibited by anti-Tac antibody that blocks 
the membrane binding and action of IL-2. We will discuss the possible involve- 
ment of an IL-2 receptor system in the B cell immune response. 
Materials and Methods 
Cell Separations.  Peripheral blood mononuclear cells from normal volunteers were 
isolated by Ficoll-Paque (Pharmacia, Inc., Uppsala, Sweden) density gradient centrifuga- 
tion. To obtain a  B cell-enriched population, T  cells and adherent cells were depleted 
(7). T  cell depletion was accomplished by twice removing by Ficoll-Paque centrifugation 
the cells that rosetted with 2-aminoethylisothiouronium bromide hydrobromide (AET)- 
treated sheep erythrocytes (E). Adherent cells were removed by the adherence to plastic 
dishes for 60 rain at 37°C. The resulting B cell-enriched population, used as B cells, 
contained <0.1%  E-rosetting cells  and  80-90%  surface immunoglobulin (sIg)-positive 
cells, when stained by the fluorescein isothiocyanate (FITC)-conjugated F(ab')z  fraction 
of goat anti-human Ig (Cappel  Laboratories, Cochranviile, PA). T  cell-enriched popula- 
tions, also obtained by twice centrifuging E-rosetting cells through FicolI-Paque, contained 
>95% E-rosetting cells and <1% sIg-positive  cells. 
Cell Activation  with SAC.  B or T  cells (4  ×  106) suspended in 2 ml of RPMI  1640 
medium containing 10% fetal calf serum (FCS) and 30 ~g/ml of gentamycin were cultured 
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with various indicated concentrations of SAC (Immusorbin; Wako Pure Chemical Indus- 
tries, Osaka, Japan) in Falcon 2006 round-bottom tubes for 3 d at 37°C under 5% COs. 
Cultured cells were filtered through meshes (50 t~m pore size) to remove large fragments 
of SAC that might interfere with flow cytofluorometry. 
Anti-Tac Antibody and Detection of Tac Antigen on the Celt Surface.  The IgG fraction of 
the antibody from hybridoma ascites was purified by the gel and DEAE cellulose chro- 
matography. After pepsin digestion, the F(ab')2  fraction was separated by gel filtration 
and protein A-Sepharose (Pharmacia, Inc.) affinity chromatography, followed by conju- 
gation with FITC (Sigma Chemical Co., St.  Louis, MO).  For the direct staining of Tac 
antigen on the cell surface, cells (1 ×  106) were incubated (4 °C, 30 rain) with a saturating 
concentration (10 #g/ml) of FITC-conjugated F(ab')~ fraction of anti-Tac antibody (FITC- 
anti-Tac), and washed twice with Hanks' balanced salt solution containing I  mg/ml of 
bovine serum albumin (BSA) and 0.1% sodium azide. All samples were analyzed by flow 
cytofluorometry (Spectrum III; Ortho Diagnostic Systems, Westwood, MA). 
Two-Color Fluorescence Analysis (8).  SAC-activated B cells were simultaneously stained 
with anti-Tac and anti-human Ig. B cells (1 ×  106) were sequentially incubated at 4°C for 
30 rain (with thorough washing after each reagent) with 10 #g]ml of anti-Tac IgG, 10 
#g/ml of biotinyl horse anti-mouse IgG (Vecter Laboratories, Inc., Burlingame, CA), 5 #1 
ofphycoerythrin (PE)-conjugated avidin (Avidin PE; Becton Dickinson Monoclonal Center 
Inc., Mountain View, CA), and FITC-anti-human Ig. Samples were passed on Spectrum 
III using an argon ion laser at 488 nm excitation wavelength. Green fluorescence (515- 
530 nm wavelength) from FITC, and red (>630 nm) from PE were detected independently 
and displayed as dot plots in the logarithmic scale of fluorescence intensity. 
Assay for B Cell Proliferation.  IL-2, purified from culture supernatants of Jurkat cell 
line by an affinity column coupled with anti-IL-2 monoclonal antibody, was generously 
provided by Dr. K. A. Smith (9). B cell proliferation induced by IL-2 was determined by 
the method of Muraguchi and Fauci (7). Briefly, SAC-activated B celt blasts were prepared 
by culturing resting B cells (2 ×  106/ml) with SAC (10  -4 vol/vol) for 3 d. These blasts (5 
×  104) in  200  #1  of medium were cultured with a  twofold dilution series of IL-2  in 
triplicate in a 96-well plate. B cell proliferation, as indicated by the incorporation of 0.5 
#Ci/well of [3H]thymidine (2 Ci/mol; Amersham Japan, Tokyo), was measured during the 
last  16 h of a  72-h culture. In the experiments of the inhibition of IL-2-induced B cell 
proliferation  by anti-Tac antibody,  the  antibody (10-10 -s  #g/ml)  was  added  to  the 
triplicated cultures of SAC-activated B cell blasts (5 ×  104/well) plus 0.5 U/ml of IL-2. 
The percent inhibition was calculated by the following formula: Percent inhibition =  100 
×  [1  -  (cpm experimental -  cpm medium control)/(cpm IL-2 control -  cpm medium 
control)], where medium control is the culture with medium alone (3,069 _+ 42 cpm) and 
IL-2 control is 12,443  _+ 592 cpm. 
Results and Discussion 
Tac Expression of Activated Normal B  Cells.  To examine whether Tac antigen 
is  expressed  on activated  B  cells, freshly separated  B  cells (2  ×  106/ml)  were 
cultured  for  3  d  with  SAC,  a  B  cell  mitogen  (7),  at  various  concentrations. 
Cultured B cells were stained with FITC-conjugated F(ab')2 fraction of anti-Tac 
antibody to avoid the binding of anti-Tac to B cells via Fc receptors.  As shown 
in Table I, the expression of Tac antigen was clearly observed on B cells activated 
by SAC at >10 -4  concentration (vol/vol), when analyzed by Spectrum  III.  In 
contrast, B cells cultured with medium alone did not express Tac antigen. Fig. 
1A  shows  the  representative  fluorescence pattern  of Tac  antigen  on  B  cells 
activated by  10 -4 (vol/vol) of SAC, indicating the wide distribution of fluores- 
cence intensity. Under the same conditions, however,  normal T  cells were not 
stimulated by SAC to express Tac antigen (<1%) (Fig.  1 B). 014  TSUDO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Expression of Tac Antigen on SAC-activated B Cells 
Tac  ÷ Cells 
Cultured with:  (mean -+ SEM, n = 5) 
% 
Medium alone  1.5 +-- 0.5 
SAC 10 -~ (vol/vol)  22.7 + 6.2 
10  -4  19.2 -+ 1,5 
10  -~  3.7 +  1,0 
10 -6  3,2 -.-+ 0.8 
B cells were  cultured  with  SAC for 3 d,  then stained  with the  FlTC-conjugated 
F(ab')~ fraction  ofanti-Tac antibody. 
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FICURE  1.  The fluorescence profile of Tac antigen on SAC-activated B cells (A) and T  cells 
(B).  Cells  were cultured  with  SAC  (10 -4  vol/vol) for  3  d,  stained  by  the  FITC-conjugated 
F(ab')2 fraction of anti-Tac antibody, and analyzed by the Spectrum l l] (linear scale).  Dotted 
fines are nonstaining controls. 
Two-color Fluorescence Analysis.  Although  T  cell contamination  in the B cell 
population  was  <0.1%,  we  performed  two-color  fluorescence  analysis  (8)  to 
confirm that Tac antigen  was expressed exactly on B cells, but not on T  cells or 
non-T non-B cells. SAC-activated B cells were sequentially stained with anti-Tac, 
biotinyl  anti-mouse  IgG,  and  PE-conjugated  avidin,  followed by staining  with 
FITC  anti-human  Ig.  Green  fluorescence  from  FITC  and  red  from  PE  were 
independently  detected  by  Spectrum  IlI  and  displayed  as  dot  plots.  Fig.  2D 
clearly shows that  Tac-expressing cells were included  in  the population  of sIg- 
bearing cells. Fig. 2, A, B, and C shows the controls of nonstaining, single staining 
of Tac antigen, and single-staining of sIg, respectively. 
An urgent question was then whether IL-2 generates any immune response of 
B cells by binding  to Tac antigen/IL-2  receptor.  We studied  the  proliferative 
response of SAC-activated B cells to affinity-purified IL-2. B cell blasts (5 x  104/ 
well) activated by SAC for 3 d  were cultured with serial dilutions of IL-2, and 
the proliferation  of cells was determined after an additional  3 d  of culture (7). 
As  shown  in  Fig.  3A,  SAC-activated  B  cells  proliferated  dose dependently  in 
response  to  IL-2.  In  contrast,  freshly separated  B cells,  which did  not express 
Tac antigen,  showed no detectable proliferation  when cultured with IL-2 for 3 
d, suggesting that  the prior activation  was required  for IL-2-induced prolifera- 
tion.  These  results  are  very  similar  to  observations  in  IL-2-induced  T  cell 
proliferation  (4).  Expecting  to  find  that  ]L-2-induced  B  cell  proliferation  is 
inhibited by anti-Tac antibody blocking the membrane binding and action of IL- TSUDO  ET  AL.  BRIEF  DEFINITIVE  REPORT  615 
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FIGURE 2+  Two-color fluorescence analysis of SAC-activated  B cells.  (D) Both Tac antigen 
and slg were stained as described  in Materials and Methods.  Tac  ÷ cells were included in the 
slg  + population.  (A) Nonstaining control. (B and C) Controls  of the single staining of Tac 
antigen and slg, respectively. 
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FIGURE 3.  (A) Proliferative  response of B cells to IL-2. SAC-activated B cells (5 x  104/well) 
(O) proliferated  in response to IL-2, dose dependently, whereas freshly separated B cells (5 x 
104/well) (Q) showed no detectable  proliferation.  Data represent the mean ± SEM of triplicate 
cultures.  (B) The inhibition of IL-2-induced  B cell proliferation  by anti-Tac  antibody.  SAC- 
activated  B cells  (5  ×  104/well)  were cultured in triplicate  with  0.5  U/ml of IL-2  in the 
presence of anti+Tac (O) or control IgG (0) from MPC11 mouse myeloma cells. Data represent 
the percent inhibition of [3H]thymidine incorporation. 
2 in the T  cell system, we cultured SAC-activated  B  cells with 0.5 U/ml of IL-2 
in the presense of anti-Tac  or control  mouse  myeloma (MPC1 1) ]gG at various 
concentrations, as described in Materials and Methods.  As shown in Fig. 3B, IL- 
2-induced B  cell proliferation  was remarkably inhibited by anti-Tac at very  low 
concentrations.  Similar  inhibition  was  also  observed in  the  experiments  using 616  TSUDO  ET AL  BRIEF  DEFINITIVE REPORT 
F(ab')2 fragments ofanti-Tac, indicating that the inhibition was not Fc receptor- 
mediated suppression. 
A simple and reasonable explanation for our results may be that Tac antigen 
on SAC-activated B cells is the functioning IL-2 receptor, and that these B cells 
proliferate directly in response to IL-2. However, it is still controversial whether 
IL-2 is involved in B cell growth and/or differentiation.  Some investigators (10, 
11) have suggested that  IL-2 itself plays an important role in the B cell growth, 
while Howard et al. (12) reported the possibility that  IL-2 stimulates T  cells to 
release, in turn, a B cell growth factor (BCGF) distinct from IL-2 which facilitates 
the  proliferation  of B  cells.  However,  it  is  unlikely  that  in  our  experimental 
system the target cells of IL-2 were T  cells and not SAC-activated, Tac-bearing 
B cells for the following reasons. First, the contamination of T  cells in the SAC- 
activated B cell population  was negligible (<0.5%) when  examined by staining 
with FITC-OKT3 (data not shown). Second, the residual T  cells, if any, did not 
express Tac antigen/IL-2  receptor when  stimulated  by SAC (Fig.  1 B). Collec- 
tively, the data strongly suggest that  IL-2 acts directly on SAC-activated B cells 
through the Tac antigen/IL-2 receptor. Tac antigen was not noted in our initial 
studies (1) on B cells activated with pokeweed mitogen (PWM) or Epstein-Barr 
virus,  as  measured  by complement-dependent  cytotoxity. Our  preliminary  ex- 
periments,  however,  showed  that  a  proportion  of B  cells in  peripheral  blood 
mononuclear cells activated with  PWM expressed Tac antigen  weakly but dis- 
tinctly,  when  examined  by the  more sensitive cytofluorometry after two-color 
staining (data not shown). Considering that anti-Tac at very low concentrations 
remarkably suppressed T  cell-dependent B cell Ig production by PWM (13 and 
our unpublished data),  the target  cells of anti-Tac  may be not only T  cells but 
also B cells. 
The mechanism of B cell growth and differentiation seems to be a complicated 
one in which many factors participate.  Our studies indicate that an IL-2 receptor 
system also appears to be involved in B cell immunity. 
Summary 
Two-color fluorescence analysis revealed that  Tac antigen,  which was previ- 
ously reported  to  be  restricted  to  T  cells,  was  expressed  on  a  proportion  of 
normal B cells activated by Staphylococcus aureus Cowan I (SAC). Immunoaffinity- 
purified interleukin  2 (IL-2) induced the proliferation of SAC-activated B cells, 
and  the  proliferation  was  completely  inhibited  by  anti-Tac  antibody,  which 
blocked the membrane binding and action of IL-2. These results suggest that an 
IL-2 receptor system is directly involved in the B cell immune response. 
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